Literature DB >> 27347321

Protective effects of ethanol extract from Portulaca oleracea L on dextran sulphate sodium-induced mice ulcerative colitis involving anti-inflammatory and antioxidant.

Xiaohang Yang1, Yongmei Yan2, Jiankang Li3, Zhishu Tang4, Jing Sun4, Huan Zhang2, Siyang Hao2, Aidong Wen3, Li Liu2.   

Abstract

Portulaca oleracea L., (POL) is one of commonly used medicine-food herbs and has a cosmopolitan distribution in many countries. Many studies showed that POL exhibited a wide range of pharmacological effects such as anti-inflammatory and liver complaints. In the clinical studies, POL was usually used for the treatment of UC disease and the clinical efficacy was well, but the mechanism and scientific intension was still unknown. In the present study, we studied the protective effects of the ethanol extract from POL on dextran sulphate sodium-induced UC in C57BL/6 mice model through oxidative stress and inflammatory pathway. The results demonstrated that the ethanol extract from POL could exhibit the effective protection for the DSS induced UC by increasing the colon length, decreasing body weight loss and the disease activity index score, inhibiting oxidative stress response through the MDA, NO, SOD activities, reducing the mRNA expressions of pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) and the protein expressions of TNF-α and NF-kB p65. These results may prove that POL could be considered as a useful and effective botanical compound from the edible plant to be used in UC through the oxidative stress and inflammatory activities.

Entities:  

Keywords:  Portulaca oleracea L; Ulcerative colitis; anti-inflammation; antioxidation

Year:  2016        PMID: 27347321      PMCID: PMC4891426     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  35 in total

1.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

Review 2.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 3.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 4.  Nitric oxide in inflammatory bowel disease.

Authors:  Raymond K Cross; Keith T Wilson
Journal:  Inflamm Bowel Dis       Date:  2003-05       Impact factor: 5.325

5.  The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions.

Authors:  O Parry; J A Marks; F K Okwuasaba
Journal:  J Ethnopharmacol       Date:  1993-12       Impact factor: 4.360

6.  Protective effect of myricetin in dextran sulphate sodium-induced murine ulcerative colitis.

Authors:  Jing Zhao; Tie Hong; Man Dong; Yixiao Meng; Jiaye Mu
Journal:  Mol Med Rep       Date:  2012-12-06       Impact factor: 2.952

7.  Epidemiology and natural history of inflammatory bowel diseases.

Authors:  Jacques Cosnes; Corinne Gower-Rousseau; Philippe Seksik; Antoine Cortot
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

8.  Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis.

Authors:  M Murano; K Maemura; I Hirata; K Toshina; T Nishikawa; N Hamamoto; S Sasaki; O Saitoh; K Katsu
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

9.  Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1.

Authors:  A N Rashed; F U Afifi; A M Disi
Journal:  J Ethnopharmacol       Date:  2003-10       Impact factor: 4.360

Review 10.  Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.

Authors:  Aleksandra Piechota-Polanczyk; Jakub Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-06       Impact factor: 3.000

View more
  14 in total

1.  Polysaccharide extracted from Portulacae Oleracea L. exerts protective effects against dextran sulfate sodium-induced colitis through inhibition of NF-κB.

Authors:  Zheng Wang; Li Wang; Xue Wu; Ya-Lei Pan; Pei Xie; Gang Pei; Yan-Ni Liang; Zhi-Shu Tang; Li Liu
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Portulaca oleracea L. Extract Ameliorates Intestinal Inflammation by Regulating Endoplasmic Reticulum Stress and Autophagy.

Authors:  Ziwei Zhang; Dan Qiao; Yali Zhang; Qian Chen; Yujun Chen; Yingjue Tang; Renye Que; Ying Chen; Lie Zheng; Yancheng Dai; Zhipeng Tang
Journal:  Mol Nutr Food Res       Date:  2022-01-09       Impact factor: 6.575

Review 3.  A review on botanicals with wound healing activity for pemphigus vulgaris: perspective of traditional Persian medicine and conventional medicine.

Authors:  Fatemeh Atarzadeh; Amir Mohammad Jaladat; Babak Daneshfard; Ladan Dastgheib; Mohammad Kamalinejad; Gholamreza Amin
Journal:  Avicenna J Phytomed       Date:  2017 Nov-Dec

4.  Bioactivities of 7'‑ethoxy‑trans‑feruloyltyramine from Portulaca oleracea L. and its metabolism in rats using ultra‑high‑performance liquid chromatography electrospray coupled with quadrupole time‑of‑flight mass spectrometry.

Authors:  Zheming Ying; Mingyue Jiang; Lina Wang; Xixiang Ying; Guanlin Yang
Journal:  Indian J Pharmacol       Date:  2020-06-03       Impact factor: 1.200

5.  The effect of Portulaca oleracea and α-linolenic acid on oxidant/antioxidant biomarkers of human peripheral blood mononuclear cells.

Authors:  Seydeh Negin Yahyazadeh Mashhadi; Vahid Reza Askari; Vahideh Ghorani; Gholam Ali Jelodar; Mohammad Hossein Boskabady
Journal:  Indian J Pharmacol       Date:  2018 Jul-Aug       Impact factor: 1.200

6.  Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression.

Authors:  Amira M Abdelmegid; Fadia K Abdo; Fayza E Ahmed; Asmaa A A Kattaia
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379

Review 7.  Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines.

Authors:  Peng-De Lu; Yong-Hua Zhao
Journal:  Chin Med       Date:  2020-02-10       Impact factor: 5.455

8.  Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice.

Authors:  Jiangtao Zhou; Lihua Tan; Jianhui Xie; Zhengquan Lai; Yanfeng Huang; Chang Qu; Dandan Luo; Zhixiu Lin; Ping Huang; Ziren Su; Youliang Xie
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Tryptanthrin Protects Mice against Dextran Sulfate Sodium-Induced Colitis through Inhibition of TNF-α/NF-κB and IL-6/STAT3 Pathways.

Authors:  Zheng Wang; Xue Wu; Cui-Ling Wang; Li Wang; Chen Sun; Dong-Bo Zhang; Jian-Li Liu; Yan-Ni Liang; Dong-Xin Tang; Zhi-Shu Tang
Journal:  Molecules       Date:  2018-05-02       Impact factor: 4.411

10.  Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model.

Authors:  Irfan A Rather; Vivek K Bajpai; Lew L Ching; Rajib Majumder; Gyeong-Jun Nam; Nagaraju Indugu; Prashant Singh; Sanjay Kumar; Nahid H Hajrah; Jamal S M Sabir; Majid Rasool Kamli; Yong-Ha Park
Journal:  Saudi J Biol Sci       Date:  2019-09-04       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.